Gary Bridger - 06 Jun 2022 Form 4 Insider Report for X4 Pharmaceuticals, Inc (XFOR)

Role
Director
Signature
Derek M. Meisner, attorney-in-fact
Issuer symbol
XFOR
Transactions as of
06 Jun 2022
Net transactions value
$0
Form type
4
Filing time
27 Jun 2022, 16:17:34 UTC
Previous filing
02 Jun 2021
Next filing
14 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XFOR Common Stock Award $0 +6,667 $0.000000 6,667 06 Jun 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an annual grant of restricted stock units ("RSUs") for service as a director to the Issuer. The RSUs will vest in two equal annual installments on June 6, 2023 and June 6, 2024, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date.
F2 Represents unvested RSUs.